Clinical IntuitionMINCNCT07877623
CLINICAL INTUITION is an Experience-based, Often Unconscious Assessment of a Patient's Resilience and Tolerance. It is INFLUENCED by Clinical Signs, Behavior, Functioning, and Context. While it MAY PREDICT Patient Dropout, it is Difficult to Objectify.
An observational study of Clinical Intuition, run by Erasmus Medical Center.
Trial summary
Patient selection for Phase I oncology trials is formally based on protocol-defined inclusion and exclusion criteria. In practice, however, healthcare professionals also take clinical intuition and professional experience into account when assessing suitability. Read more about this study
- Who is it for?
- Any ageHealthy volunteers can take part
- Conditions the study is for
- Clinical Intuition
- How many people
- 10 participants
- Where
- No sites listed yet
- Study dates
- 29 Oct 2026to May 2027
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Study population: Oncologists and nurse specialists involved in patient selection for Phase I trials at Erasmus MC.
Who may be able to join
- Healthcare professionals working within or closely affiliated with the Erasmus MC Phase I team.
- Direct involvement in eligibility assessment and recruitment for Phase I oncology studies.
- Ability to communicate in Dutch.
- Provision of written informed consent.
Who cannot join
- No involvement in patient selection in phase I.
- Inability or unwillingness to provide consent.
- Insufficient availability to participate in an interview.
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
About this study
Official title: More Than Inclusion Criteria. A Qualitative Study on Clinical Intuition in Patient Selection for Phase I Studies.
Patient selection for Phase I oncology trials is formally based on protocol-defined inclusion and exclusion criteria. In practice, however, healthcare professionals also take clinical intuition and professional experience into account when assessing suitability. The role of this intuitive judgment is insufficiently described in the literature, even though it may be relevant for preventing early trial discontinuation.
- Conditions
- Clinical Intuition
- Keywords
- Clinical Intuition
What is being measured
The primary outcome is the main question the study is designed to answer.
Role and value of clinical intuition
The aim of this study is to explore how healthcare professionals perceive the role and value of clinical intuition when assessing patient suitability for phase I oncology trials.
Measured: During the single-session interview (approximately 45-60 minutes)
Secondary outcomes (2)
Definition
Investigating how healthcare professionals define clinical intuition
Measured: During the single-session interview (approximately 45-60 minutes)
Identify
Identify clinical, functional, and psychosocial factors contributing to intuitive judgment.
Measured: During the single-session interview (approximately 45-60 minutes)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Oct 2026
- Study start29 Oct 2026 (estimated)
- Primary completionJan 2027 (estimated)
- Study completionMay 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Clinical IntuitionStudies of the same condition, open and under way.
- More trials run by Erasmus Medical CenterThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Other
- Enrolment
- 10 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Erasmus Medical Center
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Stephan Lugten, Erasmus Medical Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07877623
- Sponsor's protocol ID
- 15791
- Acronym
- MINC
- Status last verified
- Oct 2026
- First submitted
- 9 Oct 2026
- Last updated
- 16 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 16 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- More Than Inclusion Criteria. A Qualitative Study on Clinical Intuition in Patient Selection for Phase I Studies.
- ClinicalTrials.gov ID
- NCT07877623
- Acronym / sponsor ID
- MINC / 15791
- Conditions
- Clinical Intuition
- Keywords
- Clinical Intuition
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 10 participants (estimated)
- Lead sponsor
- Erasmus Medical CenterUniversity, hospital or other
- Study start
- 29 Oct 2026 (estimated)
- Primary completion
- Jan 2027 (estimated)
- Study completion
- May 2027 (estimated)
- First posted
- 16 Oct 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Patient selection for Phase I oncology trials is formally based on protocol-defined inclusion and exclusion criteria. In practice, however, healthcare professionals also take clinical intuition and professional experience into account when assessing suitability. The role of this intuitive judgment is insufficiently described in the literature, even though it may be relevant for preventing early trial discontinuation.
Study design
- Observational model
- Other
- Time perspective
- Other
Who may qualify
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Oncologists and nurse specialists involved in patient selection for Phase I trials at Erasmus MC.
Key inclusion criteria (4 listed)
- Healthcare professionals working within or closely affiliated with the Erasmus MC Phase I team.
- Direct involvement in eligibility assessment and recruitment for Phase I oncology studies.
- Ability to communicate in Dutch.
- Provision of written informed consent.
Key exclusion criteria (3 listed)
- No involvement in patient selection in phase I.
- Inability or unwillingness to provide consent.
- Insufficient availability to participate in an interview.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Role and value of clinical intuition
Time frame: During the single-session interview (approximately 45-60 minutes)
The aim of this study is to explore how healthcare professionals perceive the role and value of clinical intuition when assessing patient suitability for phase I oncology trials.
2 secondary outcomes
Definition
Time frame: During the single-session interview (approximately 45-60 minutes)
Identify
Time frame: During the single-session interview (approximately 45-60 minutes)
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Oct 2026.
Related trials for Clinical Intuition
RecruitingObservational study
Surgical Intuition in Anastomotic Leakage After Colorectal Surgery
Anastomotic Leaks
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Questions about this trial
What is this clinical trial studying?
An observational study of Clinical Intuition, run by Erasmus Medical Center.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 16 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Stephan Lugten (+31652905479, s.lugten@erasmusmc.nl), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Role and value of clinical intuition (time frame: During the single-session interview (approximately 45-60 minutes)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Oct 2026.